Prevalence of opportunistic infections in Syrian inflammatory bowel disease patients on biologic therapy: a multi-center retrospective cross-sectional study
Abstract Background Hepatitis B, hepatitis C, cytomegalovirus (CMV), and tuberculosis (TB) pose significant risks to patients with inflammatory bowel disease (IBD) receiving biological therapy. However, data on the prevalence of these infections in Syria are scarce. Methods We conducted a retrospect...
Saved in:
| Main Authors: | Marouf Alhalabi, Hussam Aldeen Alshiekh, Shadi Alsaiad, Mouayad Zarzar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11063-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Crime detective: towards the first description of inflammatory bowel diseases
by: V. V. Balutsky, et al.
Published: (2024-08-01) -
Anemia in Inflammatory Bowel Disease: A Neglected Issue in Comprehensive Inflammatory Bowel Disease Management
by: Randy Adiwinata, et al.
Published: (2021-10-01) -
Inflammatory Bowel Diseases: the Surgical Perspective
by: SOCEA Bogdan, et al.
Published: (2019-03-01) -
Can inflammatory bowel disease be treated with diet?
by: J P Wright
Published: (2025-04-01) -
Metabolic Disorders and Inflammatory Bowel Diseases
by: Hye Kyung Hyun, et al.
Published: (2025-05-01)